Resultados de la búsqueda 321-330 of 1758 for Off-label
A side effect is anything a drug does to the body besides treating your disease. Participants in this study have colorectal cancer that has spread through the ...
... out of specification leukapheresis product and/or manufactured tisagenlecleucel out of specification for commercial release. Trimethoprim-sulfamethoxazole ...
Además, seguimos las pautas de la Endocrine Society (Sociedad de Endocrinología) respecto de la salud transgénero. Mayo Clinic ofrece una gama completa de ...
Rochester, Minn. The purpose of this study is to evaluate how well the combination of avelumab with liposomal doxorubicin with or without binimetinib, or the ...
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?
... out of specification leukapheresis product and/or manufactured tisagenlecleucel out of specification for commercial release. Tebentafusp Regimen Versus ...
Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...
All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...
This is an open label, phase I/II, multi-center study in adult participants with metastatic hormone sensitive prostate cancer (mHSPC) and with metastatic ...
Mayo Clinic Minute: New rule for 'healthy' food labels Jan. 20, 2025, 03 ... Fight off the flu with immune-boosting nutrients Dec. 14, 2023, 02:30 p.m. ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.